Roshan George, MD
Retina Specialist · Texarkana, TXNPI 1255751442
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,307 and has fallen 61.7% since, to $501 in 2025.
Across 128 payments — averaging $29.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$886
- Alimera Sciences, Inc.$505
- Astellas Pharma US Inc$258
- Genentech USA, Inc.$235
- Biotissue Holdings Inc.$207
- Regeneron Healthcare Solutions, Inc.$202
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,753100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $886 |
| Alimera Sciences, Inc. | 3 | $505 |
| Astellas Pharma US Inc | 10 | $258 |
| Genentech USA, Inc. | 7 | $235 |
| Biotissue Holdings Inc. | 9 | $207 |
| Regeneron Healthcare Solutions, Inc. | 4 | $202 |
| Alcon | 5 | $178 |
| Mallinckrodt Hospital Products Inc. | 4 | $165 |
| Apellis Pharmaceuticals, Inc. | 4 | $142 |
| Bausch & Lomb Americas Inc. | 4 | $137 |
| Coherus Oncology, Inc. | 5 | $135 |
| Sandoz | 5 | $123 |
| Novartis | 5 | $111 |
| ANI Pharmaceuticals, Inc. | 5 | $101 |
| Oyster Point Pharma, Inc. | 4 | $91 |
| Aerie Pharmaceuticals, Inc. | 4 | $59 |
| Rayner Intraocular Lenses Limited | 3 | $58 |
| Rxsight Inc | 2 | $40 |
| Tarsus Pharmaceuticals, Inc. | 2 | $35 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $33 |
| Thea Pharma Inc. | 1 | $19 |
| Kala Pharmaceuticals, Inc. | 1 | $18 |
| Omeros Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,753 in reported general payments places this provider in the 60th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 166 | $5,294 |
| MoxifloxacinMoxifloxacin Hcl | 86 | $2,424 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 125 | $1,959 |
| ErythromycinErythromycin Base | 91 | $970 |
| Brimonidine Tartrate | 80 | $754 |
| Acetazolamide ErAcetazolamide | 16 | $545 |
| Latanoprost | 84 | $538 |
| Timolol Maleate | 24 | $67 |
| Prednisone | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Texarkana
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Hemang PandyaPlano$153K
- Margaret RunnerSouthlake$71K
- Moises ChicaSan Antonio$43K
- Garvin DavisHouston$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.